Organogenesis Holdings Inc (NASDAQ: ORGO) kicked off on Tuesday, up 4.50% from the previous trading day, before settling in for the closing price of $4.67. Over the past 52 weeks, ORGO has traded in a range of $2.21-$6.71.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 14.32%. While this was happening, its average annual earnings per share was recorded 625.00%. With a float of $64.38 million, this company’s outstanding shares have now reached $125.73 million.
The extent of productivity of a business whose workforce counts for 869 workers is very important to gauge. In terms of profitability, gross margin is 74.32%, operating margin of -0.27%, and the pretax margin is -0.58%.
Organogenesis Holdings Inc (ORGO) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Organogenesis Holdings Inc is 49.24%, while institutional ownership is 47.81%. The most recent insider transaction that took place on Mar 04 ’25, was worth 127,000. Before that another transaction happened on Mar 04 ’25, when Company’s Director sold 25,000 for $5.10, making the entire transaction worth $127,535. This insider now owns 166,879 shares in total.
Organogenesis Holdings Inc (ORGO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 625.00% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Take a look at Organogenesis Holdings Inc’s (ORGO) current performance indicators. Last quarter, stock had a quick ratio of 3.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.28. Likewise, its price to free cash flow for the trailing twelve months is 148.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.01, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach 0.19 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
The latest stats from [Organogenesis Holdings Inc, ORGO] show that its last 5-days average volume of 1.79 million was superior to 1.75 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 88.98%. Additionally, its Average True Range was 0.33.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 52.28%, which indicates a significant decrease from 98.18% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.39% in the past 14 days, which was lower than the 135.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.49, while its 200-day Moving Average is $3.50. Now, the first resistance to watch is $4.98. This is followed by the second major resistance level at $5.07. The third major resistance level sits at $5.24. If the price goes on to break the first support level at $4.72, it is likely to go to the next support level at $4.55. The third support level lies at $4.45 if the price breaches the second support level.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
The company with the Market Capitalisation of 618.92 million has total of 126,828K Shares Outstanding. Its annual sales at the moment are 482,040 K in contrast with the sum of 860 K annual income. Company’s last quarter sales were recorded 126,660 K and last quarter income was 7,670 K.
